Earnings History Data for Trevena (TRVN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Trevena

Trevena, Inc. is a biopharmaceutical company. It focuses on discovering and developing therapeutics for G protein coupled receptors. The Company's product pipeline includes TRV027, TRV130, TRV734 and Delta opioid biased ligand which are in different clinical phases. Trevena, Inc. is based in King of Prussia, Pennsylvania.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
01-04-2024	PM		TRVN	Trevena	8.00	-1.06	-0.52	0.00		0.4050	-0.06 (-11.96%)	0.45	-0.01 (-2.20%)	0.39 - 3.28	396,717	150,000	13,941

14-11-2023	PM		TRVN	Trevena, Inc.	7.82	-0.57	0.00	-2.25	Trevena GAAP EPS of -$0.57 misses by $0.42, revenue of $0.18M beats by $0.08M [11/14/2023 7:05 AM]	0.5822	-0.02 (-2.80%)	0.57	-0.03 (-4.86%)	0.51 - 3.92	84,825	90,000	11,332
Trevena Q3 Earnings Preview [11/13/2023 10:15 AM] Trevena GAAP EPS of -$0.57 misses by $0.42, revenue of $0.18M beats by $0.08M [11/14/2023 7:05 AM]
14-08-2023	PM		TRVN	Trevena	10.00	-0.69	-0.45	0.00	Trevena GAAP EPS of -$0.69, revenue of $3.02M [8/14/2023 11:13 AM]	0.9049	0.03 (3.43%)	0.94	0.07 (7.56%)	0.58 - 6.47	182,762	110,000	36,309
Trevena GAAP EPS of -$0.69, revenue of $3.02M [8/14/2023 11:13 AM]
15-05-2023	PM	7:00 AM ET (May 15)	TRVN	Trevena, Inc.	13.64	-0.81	-0.85	-2.50	Trevena GAAP EPS of -$0.81 [5/15/2023 7:02 AM]	1.19	-0.17 (-12.22%)	1.40	0.05 (3.70%)	0.58 - 12.22	2,301,867	14,650,000	200,189
Trevena GAAP EPS of -$0.81 [5/15/2023 7:02 AM]
30-03-2023	PM	7:00 AM ET (Mar 30)	TRVN	Trevena, Inc.	8.87	-0.73	0.00	2.00	Trevena GAAP EPS of -$0.73 beats by $1.01 [3/30/2023 7:02 AM]	0.70	-0.03 (-4.12%)	0.80	0.07 (9.22%)	0.65 - 15.28	440,020	110,000	5,184
Trevena GAAP EPS of -$0.73 beats by $1.01 [3/30/2023 7:02 AM] Trevena stock rises after opioid pain drug Olinvyk shows promise in real-world studies [3/30/2023 7:44 AM]
09-11-2022	PM	7:00 AM ET (Nov 9)	TRVN	Trevena, Inc.	31.78	-0.09	-0.09	-0.08	Trevena GAAP EPS of -$0.09 in-line, revenue of -$0.44M misses by $0.88M [11/9/2022 7:04 AM]	0.1260	-0.05 (-28.56%)	0.17	-0.01 (-4.71%)	0.12 - 0.97	4,849,688	400,000	18,737
Trevena Q3 2022 Earnings Preview [11/8/2022 1:03 PM] Trevena GAAP EPS of -$0.09 in-line, revenue of -$0.44M misses by $0.88M [11/9/2022 7:04 AM]
11-08-2022	PM	7:00 AM ET (Aug 11)	TRVN	Trevena, Inc.	47.09	-0.09	-0.11	-0.09	Trevena GAAP EPS of -$0.09 beats by $0.01 [8/11/2022 7:07 AM]	0.2392	0.0 (-0.33%)	0.25	0.01 (6.25%)	0.18 - 1.42	1,419,006	1,990,000	122,324
Trevena Q2 2022 Earnings Preview [8/10/2022 1:41 PM] Trevena GAAP EPS of -$0.09 beats by $0.01 [8/11/2022 7:07 AM] Trevena Reports Second Quarter 2022 Results and Provides Business Update [Aug-11-22 07:00AM]
11-05-2022	PM	7:00 AM ET (May 11)	TRVN	Trevena, Inc.	41.81	-0.10	-0.09	-0.06	Trevena GAAP EPS of -$0.10, revenue of $0.02M [5/11/2022 7:02 AM]	0.1958	-0.09 (-31.82%)	0.22	-0.06 (-21.66%)	0.18 - 2.20	3,597,394	1,290,000	136,748
Trevena Q1 2022 Earnings Preview [5/10/2022 12:16 PM] Trevena GAAP EPS of -$0.10, revenue of $0.02M [5/11/2022 7:02 AM] Trevena stock falls 30% as Q1 net loss widens Y/Y [5/11/2022 10:59 AM] Reata Pharmaceuticals, Inc. (RETA) Reports Q1 Loss, Misses Revenue Estimates [May-10-22 07:55AM] Trevena Reports First Quarter 2022 Results and Provides Business Update [May-11-22 07:00AM] Trevena (TRVN) Reports Q1 Loss, Lags Revenue Estimates [May-11-22 08:15AM]
31-03-2022	PM	7:00 AM ET (Mar 31)	TRVN	Trevena	76.00	-0.08	-0.09	0.00	Trevena GAAP EPS of -$0.08 beats by $0.02 [3/31/2022 7:01 AM]	0.5430	0.10 (23.07%)	0.48	0.04 (8.79%)	0.40 - 2.31	10,089,497	950,000	212,424
Trevena GAAP EPS of -$0.08 beats by $0.02 [3/31/2022 7:01 AM] Trevena Q4 2021 Earnings Preview [3/30/2022 1:12 PM] Trevena stock soars 30% amid Q4 results, $40M financing on pain drug Olinvyk [3/31/2022 11:12 AM] Trevena Receives up to $40M in OLINVYK ex-US Royalty-Based Financing from R-Bridge Healthcare Fund, an affiliate of CBC Group [Mar-31-22 07:02AM] Trevena Reports Fourth Quarter and Full Year 2021 Results [Mar-31-22 07:00AM] Trevena to Release Fourth Quarter and Full Year 2021 Financial Results on March 31, 2022 [Mar-30-22 07:00AM] Trevena (TRVN) Reports Q4 Loss, Lags Revenue Estimates [Mar-31-22 08:15AM] Trevena shares skyrocket on $40 million royalty-based financing deal [Mar-31-22 11:26AM]
15-11-2021	PM	7:00 AM ET (Nov 15)	TRVN	Trevena, Inc.	147.32	-0.08	-0.09	-0.04	Trevena EPS beats by $0.01, misses on revenue [11/15/2021 7:02 AM]	0.8322	-0.10 (-10.99%)	0.89	-0.05 (-4.81%)	0.74 - 3.10	10,386,291	1,720,000	382,287
Trevena EPS beats by $0.01, misses on revenue [11/15/2021 7:02 AM] Trevena Reports Third Quarter 2021 Results [Nov-15-21 07:00AM] Trevena (TRVN) Reports Q3 Loss, Lags Revenue Estimates [Nov-15-21 12:25PM]
12-08-2021	PM	7:00 AM ET (Aug 12)	TRVN	Trevena, Inc.	236.89	-0.09	-0.08	-0.06	Trevena EPS misses by $0.02, misses on revenue [8/12/2021 7:12 AM]	1.25	-0.15 (-10.71%)	1.24	-0.16 (-11.43%)	1.15 - 3.40	5,236,221	1,680,000	550,168
Trevena EPS misses by $0.02, misses on revenue [8/12/2021 7:12 AM] Trevena Reports Second Quarter 2021 Results [Aug-12-21 07:00AM] Trevena (TRVN) Reports Q2 Loss, Misses Revenue Estimates [Aug-12-21 09:55AM]
06-05-2021	PM	7:00 AM ET (May 6)	TRVN	Trevena, Inc.	270.94	-0.06	-0.08	-0.06	Trevena EPS beats by $0.02, misses on revenue [5/6/2021 7:10 AM]	1.63	-0.14 (-7.91%)	1.61	-0.02 (-1.23%)	0.83 - 3.68	7,162,736	3,250,000	1,163
Trevena EPS beats by $0.02, misses on revenue [5/6/2021 7:10 AM] Trevena to Release First Quarter 2021 Financial Results on May 6, 2021 [May-05-21 07:00AM] Trevena Announces TRV027 Selected by NIH-Funded ACTIV Initiative For COVID-19 Trial [May-06-21 07:03AM] Trevena Reports First Quarter 2021 Results [May-06-21 07:00AM] Trevena Announces TRV027 Selected by NIH-Funded ACTIV Initiative For COVID-19 Trial [May-06-21 07:03AM] Trevena Reports First Quarter 2021 Results [May-06-21 07:00AM] Trevena's TRV027 To Be Tested In NIH-Funded COVID-19 Trial [May-06-21 10:29AM] Trevena, Inc. to Host Earnings Call [May-06-21 06:15AM]
09-03-2021	PM	0:00 AM ET (Mar 9)	TRVN	Trevena, Inc.	328.19	-0.08	0.00	-0.07	Trevena EPS misses by $0.01, misses on revenue [3/9/2021 7:01 AM]	2.04	-0.01 (-0.49%)	2.03	-0.02 (-0.98%)	0.46 - 3.68	4,247,486	3,962,226	479,188
Trevena EPS misses by $0.01, misses on revenue [3/9/2021 7:01 AM] Trevena, Inc. Reports Fourth Quarter and Full Year 2020 Results [Mar-09-21 07:00AM] Trevena, Inc. to Host Earnings Call [Mar-09-21 05:15AM] Earnings Scheduled For March 9, 2021 [Mar-09-21 04:09AM]